News Current page: 14

The high-tech company Crystal GmbH produces and processes diffusion-joined laser crystals, substrates for thin-film applications and optical components, among other things. In the field of crystal processing, Crystal is one of the leading suppliers and an important supplier to the medical technology industry. SHS invested in Crystal from its Fund II and is now handing […]

Dipl.-Ing. Marcus Raguse joined the management team of SHS portfolio company Novo Klinik-Service GmbH in May 2021. Novo offers medical aids and medical technology solutions. The graduate engineer brings with him a great deal of experience and know-how in the healthcare sector and, together with Ulrich Frick, who has been Managing Director since January 2021, […]

The company c-LEcta is one of the world’s leading biotech companies in the field of enzyme production. More than 200 customers in 40 countries, including well-known pharmaceutical companies, rely on the enzyme products from Leipzig. 2020 was a successful year for c-LEcta, in which the 10 million euro mark in turnover was broken for the […]

With the appointment of Dr. Alan Levy as Chairman of the Board, the Dutch growth company Salvia BioElectronics brings profound life science expertise and decades of experience to the team. Dr Levy has successfully exited four out of five early-stage healthcare companies and also sits on the board of Intuitive Surgical. Salvia develops electromedical neurostimulation […]

Dentist appointment 14,000 years ago Regular visits to the dentist are part of our natural health routines throughout the year, even if not every appointment in the dental chair is equally pleasant. But we should not complain, but feel privileged, as a look at the history of dentistry shows. It begins about 14,000 years ago […]

Afinum and SHS Capital have sold their stakes in Switzerland-based diagnostic and therapeutic antibodies specialist Evitria toSweden-based Atlas Antibodies in a deal that values Evitria atmore than EUR 200m.

Atlas Antibodies acquires evitria Atlas Antibodies has agreed to acquire evitria, a world leader in transient recombinant antibody expression in CHO cells. This transformative acquisition brings together a leading provider of highly validated research antibodies and a front-runner in the field of custom recombinant antibody expression. Since its inception in 2010, evitria has been singularly […]

An interview with Dr Hanno Kühn, Chief Investment Officer (CIO) and head of apoBank’s institutional investment business, and Hubertus Leonhardt, Managing Director and partner of SHS Gesellschaft für Beteiligungsmanagement mbH. Düsseldorf and Tübingen , 22.7.2021 As the largest cooperative primary bank in Germany, apoBank is the number one financial services provider in the health care […]

An interview with Dr Hanno Kühn, Chief Investment Officer (CIO) and head of apoBank’s institutional investment business, and Hubertus Leonhardt, Managing Director and partner of SHS Gesellschaft für Beteiligungsmanagement mbH. As the largest cooperative primary bank in Germany, apoBank is the number one financial services provider in the health care sector. Its business activities include […]

Artificial intelligence will revolutionise the healthcare sector in this decade. With smart concepts and innovative healthtech products, we can make the healthcare system more efficient and effective.

The Tübingen-based healthcare investor SHS has accompanied Crystal GmbH on its growth path with its know-how, the required capital and extensive networks. Crystal’s optical components are used, for example, in the medical technology industry in respirators and as diffusion-bonded laser crystals in the manufacture of laser systems. The new investor Silver Investment Partners (SIP) will […]

For the future performance and efficiency in medical care, the degree of digitalisation will be decisive, in addition to the qualified specialist staff.